HLA-C and neoplasm: EP0569678A2 [23] and US5750102A [24] (“Double transfectants of the MHC genes as cellular vaccines for immune prevention of tumor metastasis”) are similar to WO20171-47600A1 [22] in that claims relate to the overexpression of HLA alleles in tumor cells but co-expression of cytokines is not claimed.